IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11040937 B1

PDFFull Text
Date of Patent:
Jun. 22, 2021

Filed:

Feb. 27, 2015

Amide derivative

Applicants:

Tohoku University, Sendai, JP;

National University Corporation Gunma University, Maebashi, JP;

Fuso Pharmaceutical Industries, Ltd., Osaka, JP;

Inventors:

Haruhisa Kikuchi, Sendai, JP;

Yoshiteru Oshima, Sendai, JP;

Toshio Hattori, Kurashiki, JP;

Yuzuru Kubohara, Sakura, JP;

Osamu Yamada, Kobe, JP;

Jing Zhang, Osaka, JP;

Yoshihisa Matsushita, Osaka, JP;

Shinya Kida, Akashi, JP;

Assignees:

TOHOKU UNIVERSITY, Miyagi, JP;

NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY, Gunma, JP;

FUSO PHARMACEUTICAL INDUSTRIES, LTD., Osaka, JP;

Attorney:

Hamre, Schumann, Mueller & Larson, P.C.

Primary Examiner:

Savitha M Rao

Assistant Examiner:

Andrew P Lee

Int. Cl.
CPC ...
C07C 235/50 (2006.01); C07C 235/48 (2006.01); C07C 233/36 (2006.01); C07C 233/78 (2006.01); C07C 233/62 (2006.01); C07D 309/08 (2006.01); C07D 471/04 (2006.01); C07D 213/81 (2006.01); C07C 235/60 (2006.01); C07C 237/22 (2006.01); C07C 237/42 (2006.01); C07D 209/14 (2006.01); C07C 237/34 (2006.01); A61K 31/437 (2006.01); A61K 31/4045 (2006.01); A61K 31/4409 (2006.01); A61K 31/445 (2006.01); A61K 31/40 (2006.01); A61K 31/351 (2006.01); A61K 31/167 (2006.01); A61K 31/381 (2006.01); A61K 31/397 (2006.01); A61K 31/166 (2006.01); A61K 31/165 (2006.01); C07D 205/04 (2006.01); C07D 207/16 (2006.01); C07D 211/60 (2006.01); C07D 333/38 (2006.01);
U.S. Cl.
CPC ...
C07C 235/50 (2013.01); A61K 31/165 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/351 (2013.01); A61K 31/381 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/4045 (2013.01); A61K 31/437 (2013.01); A61K 31/445 (2013.01); A61K 31/4409 (2013.01); C07C 233/36 (2013.01); C07C 233/62 (2013.01); C07C 233/78 (2013.01); C07C 235/48 (2013.01); C07C 235/60 (2013.01); C07C 237/22 (2013.01); C07C 237/34 (2013.01); C07C 237/42 (2013.01); C07D 205/04 (2013.01); C07D 207/16 (2013.01); C07D 209/14 (2013.01); C07D 211/60 (2013.01); C07D 213/81 (2013.01); C07D 309/08 (2013.01); C07D 333/38 (2013.01); C07D 471/04 (2013.01); C07C 2601/14 (2017.05);
Abstract

The present invention provides a useful medicament for the treatment and/or prophylaxis of a disease associated with the enhancement of OPN production including cancer, which comprises a compound of formula: wherein R, R, R, R, R, R, R, m, n, p, X, and Y are as defined in the specification, a pharmaceutically acceptable salt thereof.

Find Patent Forward Citations

Loading…